Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent

Abstract PC945 is a novel antifungal triazole formulated for nebulized delivery to treat lung Aspergillus infections. Pharmacokinetic and safety profiles from nonclinical studies and clinical trials in healthy subjects, and subjects with mild asthma were characterized. Toxicokinetics were assessed f...

Full description

Bibliographic Details
Main Authors: Lindsey Cass, Alison Murray, Amanda Davis, Kathy Woodward, Muna Albayaty, Kazuhiro Ito, Pete Strong, John Ayrton, Charlie Brindley, Jayne Prosser, John Murray, Eddie French, Phillip Haywood, Christopher Wallis, Garth Rapeport
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Pharmacology Research & Perspectives
Subjects:
antifungal
drug‐drug interaction
first‐in‐human
inhaled administration
PC945
pharmacokinetics
Online Access:https://doi.org/10.1002/prp2.690

Internet

https://doi.org/10.1002/prp2.690

Similar Items